Diagnostic value of blood clot core during endobronchial ultrasound-guided transbronchial needle aspirate

Emily N. Amin, Christopher D. Russell, Konstantin Shilo, Shaheen Islam, Karen L. Wood

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is being increasingly used in the sampling of pulmonary masses and mediastinal lymphadenopathy. The blood clot core (BCC) often obtained during EBUS-TBNA may not be a true core and therefore may not be submitted for histological analysis. The frequency in which the blood clot core is positive in patients with negative cytology undergoing EBUS-TBNA is not known. The purpose of this study was to evaluate the diagnostic role of the blood clot core obtained during EBUS-TBNA. Methods: An Institutional Review Board-approved retrospective chart review was performed from January through September 2011 for all patients who underwent EBUS-TBNA at The Ohio State University. The data collection included cytology and histology results for each procedure. Blood clot cores obtained from the EBUS-TBNA needle were sent in formalin for histological examination. Results: Seventy patients underwent EBUS-TBNA and 51 (72.8 %) patients had procedures that yielded a BCC for histology and aspirate for cytology. Forty-nine percent of patients with a BCC were diagnosed with malignancy. Of those with a BCC obtained, five (9.8 %) patients diagnosed with malignancy were done so based only on the results of blood clot core alone with negative cytology. Conclusions: Blood clot cores obtained at EBUS-TBNA contain diagnostic material and should be subjected histopathological examination. When blood clot cores are sent for analysis, there is the potential to spare up to 10 % of patients more invasive diagnostic biopsy procedures.

Original languageEnglish (US)
Pages (from-to)305-309
Number of pages5
JournalLung
Volume191
Issue number3
DOIs
StatePublished - Jun 1 2013
Externally publishedYes

Fingerprint

Needles
Thrombosis
Cell Biology
Histology
Research Ethics Committees
Formaldehyde
Neoplasms
Biopsy
Lung

Keywords

  • Core biopsy
  • Endobronchial ultrasound
  • Mediastinal lymph node
  • Mediastinal staging
  • Transbronchial needle aspiration

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Diagnostic value of blood clot core during endobronchial ultrasound-guided transbronchial needle aspirate. / Amin, Emily N.; Russell, Christopher D.; Shilo, Konstantin; Islam, Shaheen; Wood, Karen L.

In: Lung, Vol. 191, No. 3, 01.06.2013, p. 305-309.

Research output: Contribution to journalArticle

Amin, Emily N. ; Russell, Christopher D. ; Shilo, Konstantin ; Islam, Shaheen ; Wood, Karen L. / Diagnostic value of blood clot core during endobronchial ultrasound-guided transbronchial needle aspirate. In: Lung. 2013 ; Vol. 191, No. 3. pp. 305-309.
@article{ea918fb0ee43435ab24d72930c5d0a39,
title = "Diagnostic value of blood clot core during endobronchial ultrasound-guided transbronchial needle aspirate",
abstract = "Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is being increasingly used in the sampling of pulmonary masses and mediastinal lymphadenopathy. The blood clot core (BCC) often obtained during EBUS-TBNA may not be a true core and therefore may not be submitted for histological analysis. The frequency in which the blood clot core is positive in patients with negative cytology undergoing EBUS-TBNA is not known. The purpose of this study was to evaluate the diagnostic role of the blood clot core obtained during EBUS-TBNA. Methods: An Institutional Review Board-approved retrospective chart review was performed from January through September 2011 for all patients who underwent EBUS-TBNA at The Ohio State University. The data collection included cytology and histology results for each procedure. Blood clot cores obtained from the EBUS-TBNA needle were sent in formalin for histological examination. Results: Seventy patients underwent EBUS-TBNA and 51 (72.8 {\%}) patients had procedures that yielded a BCC for histology and aspirate for cytology. Forty-nine percent of patients with a BCC were diagnosed with malignancy. Of those with a BCC obtained, five (9.8 {\%}) patients diagnosed with malignancy were done so based only on the results of blood clot core alone with negative cytology. Conclusions: Blood clot cores obtained at EBUS-TBNA contain diagnostic material and should be subjected histopathological examination. When blood clot cores are sent for analysis, there is the potential to spare up to 10 {\%} of patients more invasive diagnostic biopsy procedures.",
keywords = "Core biopsy, Endobronchial ultrasound, Mediastinal lymph node, Mediastinal staging, Transbronchial needle aspiration",
author = "Amin, {Emily N.} and Russell, {Christopher D.} and Konstantin Shilo and Shaheen Islam and Wood, {Karen L.}",
year = "2013",
month = "6",
day = "1",
doi = "10.1007/s00408-013-9457-5",
language = "English (US)",
volume = "191",
pages = "305--309",
journal = "Lung",
issn = "0341-2040",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Diagnostic value of blood clot core during endobronchial ultrasound-guided transbronchial needle aspirate

AU - Amin, Emily N.

AU - Russell, Christopher D.

AU - Shilo, Konstantin

AU - Islam, Shaheen

AU - Wood, Karen L.

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is being increasingly used in the sampling of pulmonary masses and mediastinal lymphadenopathy. The blood clot core (BCC) often obtained during EBUS-TBNA may not be a true core and therefore may not be submitted for histological analysis. The frequency in which the blood clot core is positive in patients with negative cytology undergoing EBUS-TBNA is not known. The purpose of this study was to evaluate the diagnostic role of the blood clot core obtained during EBUS-TBNA. Methods: An Institutional Review Board-approved retrospective chart review was performed from January through September 2011 for all patients who underwent EBUS-TBNA at The Ohio State University. The data collection included cytology and histology results for each procedure. Blood clot cores obtained from the EBUS-TBNA needle were sent in formalin for histological examination. Results: Seventy patients underwent EBUS-TBNA and 51 (72.8 %) patients had procedures that yielded a BCC for histology and aspirate for cytology. Forty-nine percent of patients with a BCC were diagnosed with malignancy. Of those with a BCC obtained, five (9.8 %) patients diagnosed with malignancy were done so based only on the results of blood clot core alone with negative cytology. Conclusions: Blood clot cores obtained at EBUS-TBNA contain diagnostic material and should be subjected histopathological examination. When blood clot cores are sent for analysis, there is the potential to spare up to 10 % of patients more invasive diagnostic biopsy procedures.

AB - Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is being increasingly used in the sampling of pulmonary masses and mediastinal lymphadenopathy. The blood clot core (BCC) often obtained during EBUS-TBNA may not be a true core and therefore may not be submitted for histological analysis. The frequency in which the blood clot core is positive in patients with negative cytology undergoing EBUS-TBNA is not known. The purpose of this study was to evaluate the diagnostic role of the blood clot core obtained during EBUS-TBNA. Methods: An Institutional Review Board-approved retrospective chart review was performed from January through September 2011 for all patients who underwent EBUS-TBNA at The Ohio State University. The data collection included cytology and histology results for each procedure. Blood clot cores obtained from the EBUS-TBNA needle were sent in formalin for histological examination. Results: Seventy patients underwent EBUS-TBNA and 51 (72.8 %) patients had procedures that yielded a BCC for histology and aspirate for cytology. Forty-nine percent of patients with a BCC were diagnosed with malignancy. Of those with a BCC obtained, five (9.8 %) patients diagnosed with malignancy were done so based only on the results of blood clot core alone with negative cytology. Conclusions: Blood clot cores obtained at EBUS-TBNA contain diagnostic material and should be subjected histopathological examination. When blood clot cores are sent for analysis, there is the potential to spare up to 10 % of patients more invasive diagnostic biopsy procedures.

KW - Core biopsy

KW - Endobronchial ultrasound

KW - Mediastinal lymph node

KW - Mediastinal staging

KW - Transbronchial needle aspiration

UR - http://www.scopus.com/inward/record.url?scp=84878728106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878728106&partnerID=8YFLogxK

U2 - 10.1007/s00408-013-9457-5

DO - 10.1007/s00408-013-9457-5

M3 - Article

VL - 191

SP - 305

EP - 309

JO - Lung

JF - Lung

SN - 0341-2040

IS - 3

ER -